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The discovery of the TL system of thymocyte-surface antigens, and the finding that 
the  Tla  locus  is  situated  next  to  H-2D,  were  followed  by the  development  of the 
congenic strains B6-Tla" and A-Tla b derived from recombinants between H-2D and 
Tla (1). These recombinant congenic strains served to isolate the  Tla region from the 
major histocompatibility  complex, commonly defined  as  the  region  from H-2K  to 
H-2D. Thereafter the usual antiserum used for TL typing ofthymocytes and leukemias 
was prepared by immunizing (B6 X A-Tla  b) TL- hybrids with A strain cells (genotype 
Tla  a,  phenotype  TL.1,2,3).  Subsequently  this  antiserum  was  found  to  react  with 
peripheral  lymphocytes, and  these  reactions  proved to be distinct  from TL  (2),  as 
expected  from  the  restriction  of TL  antigens  to  thymocytes. The  antigenic  system 
defined by the reactions of (B6  ×  A-Tla b) a-A-strain serum with peripheral lympho- 
cytes is referred to as the Qa-1 system, and the antiserum when used in this context 
is called a-Qa-1. We report here the Qa-1 phenotypes of peripheral T  cells according 
to cytotoxicity assays, mitogen responses, and the effects of excluding Qa-1 + cells from 
assays of immune function in vitro. 
We do not  yet know how complex the Qa-1  system may be.  Thus  when  two or 
more cell sets are denoted Qa-I  + on the basis of their reactions with Qa-1 antiserum, 
it is not implied that they necessarily express the same Qa-1 antigen. The Qa-1 system 
may comprise more than one cell-surface component, determined by different genes 
in the region spanning the  Tla locus. 
Materials and Methods 
Animals.  Except for C57BL/6J  (B6), obtained from The Jackson Laboratory, Bar Harbor, 
Maine, all  mice were bred at Memorial Sloan-Kettering Cancer Center or the Dana Cancer 
Center, and were used at 6- to 12-wk of afte. 
Antisera.  The antiserum (B6  X A-Tla  ) anti-A strain leukemia ASL1, called ~t-TL. 1,2,3 in 
reference to its reactions with thymocytes, is referred to in the text as t~-Qa-1 in reference to its 
reactions  with  peripheral  T  cells  (Introduction).  The  a-Thy-l.2  serum  was  prepared  by 
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immunization of Thy-1  congenic mice. The preparation  and  use of Ly antisera  are described 
elsewhere (3, 4). 
Complement.  This study was conducted with pools of rabbit serum that had been rigorously 
screened  and  selected  for  high complement  levels combined  with  low  inherent  cytotoxicity, 
usually four to five rabbits out of 30 were chosen, as described in reference (2) which also gives 
details of cytotoxicity assays for Qa-1  and the calculation of cytotoxicity indices. 
Eliminatwn of Cell Sets  with Antibody and Complement.  20-30  ×  106 cells/ml were incubated 
with ot-Qa-I  (1:25), a-Thy-l.2 (t:40), or NMS (1:50), in either RPMI-1640 or medium  199 for 
20 min at  4°C. After washing once, the cells were resuspended  at  20-30  X  10"/ml in rabbit 
serum  diluted  1:20  (complement)  and  incubated  at  37°C  for 30 rain.  Before further use,  the 
cells were washed  twice in  medium  plus 5% fetal calf serum  (FCS). 1 The percentage of dead 
cells was determined by trypan blue exclusion. 
M,togen  Activation.  For assay  of mitogen responsiveness,  spleen cell suspensions  pretreated 
with antiserum  plus complement  (C) were adjusted  to 4  X  106 viable cells/ml and 0.1  ml was 
cultured  with  0.05  ml of either  2/zg/ml concanavalin  A  (Con  A), Sigma Chemical Co.,  St. 
Louis, Mo., 50 btg/ml lipopolysaccharide (LPS), Difco Laboratories, or phytohemagglutinin M 
(PHA-M)  (1:64;  Difco Laboratories)  in  RPMI-1640  containing  10%  FCS,  2  mM  glutamine, 
100  U/ml penicillin, and  100 p.g/ml streptomycin.  Quadruplicate  cultures were incubated  in 
16-mm round  bottom wells (Linbro Chemical Co., Hamden, Conn.)  for 48 h, at which time 2 
p,  Ci  [:3H]thymidine  was  added.  After an  additional  18  h,  the  cultures  were  terminated  and 
[:~H]thymidine incorporation assessed. 
Antibody Responses In Vitro 
PRXMARV RESPONSE.  After  treatment  with  a-Qa-1  (+C)  or  normal  mouse  serum  (NMS) 
(+C),  10  X  106 viable spleen cells were incubated  for 5 days with 3  X  106 sheep erythrocytes 
(SRBC)  (Colorado Serum Co., Denver, Colo.) according to Mishell and  Dutton  (5).  In some 
cases, a modification of this procedure was used, allowing efficient stimulation of 5  x  106 cells 
(6).  Duplicate cultures were harvested on days 4 and  5 and assayed  for direct plaque-forming 
cells by a slide modification of the Jerne plaque assay  (6). 
SECONDARY RESPONSE.  Mice were  primed  by  intraperitoneal  injection of 2  X  108 SRBC 
and pertussis vaccine containing 3  ×  10  ~ bacteria (Eli Lilly and Co. Indianapolis, Ind). 8 Days 
later, spleen cell suspensions were treated with either a-Qa-I  (+C) or NMS (+C) and 4  X  10  ~ 
remaining viable cells were incubated  for 5 days with 3  X  106 SRBC. Duplicate cultures were 
harvested on days 3, 4, and  5, and assayed  for direct and  indirect plaque-forming cells (PFC) 
as described above. Peak responses were obtained on day 4. 
Generation of Suppressive Cells.  Two methods were used: (a) SRBC-stimulated suppressor cells 
were prepared  according to Eardley and Gershon  (7).  Briefly, 3.5  ×  10 7 spleen cells from B6- 
Tla"  (Qa-1 +) mice or B6 (Qa-l-)  mice were incubated  for 3 days with  12  ×  106 SRBC in 3.5 
ml of culture  medium  in  the absence  of 2-mercaptoethanol;  (b)  Con  A-activated suppressor 
cells were prepared  as described  previously (6, 8).  Briefly, 3-4  ×  10  7 spleen cells from Qa-I + 
mice were cultured  with 2 ,ttg/ml Con A  at  a  concentration of 3-4  ×  106 cells/ml in RPMI- 
1640 containing  10% FCS, and 5  X  10 -5 M  2-mercaptoethanol. 
Mixed Lymphocyte Cultures (MLC).  Spleen cells were cultured  in RPMI-1640  (Grand  Island 
Biological  Co.,  Grand  Island,  N.  Y.)  su_p~lemented  with  100  U/ml  penicillin,  100  #g/ml 
streptomycin,  2  mM  glutamine,  5  ×  10-"  M  2-mercaptoethanol,  and  15%  heat-inactivated 
FCS.  Responding and  X-irradiated  stimulating cells (1,200  rads)  were cultured at  a  1:1  ratio 
in 20-ml vol at a concentration of 2  ×  10  ~ cells/ml of each type. Proliferation was measured on 
days  1-5 by uptake of I:3H]thymidine. Triplicate 200-/xl aliquots were removed and cultured in 
microtiter plates with 2/~Ci [:3H]thymidine for 6-8 h. Samples were harvested onto glass tibet" 
filters, and  I;~H]thymidine incorporation  was determined by liquid scintillation spectrometry. 
Cell-mediated cytotoxicity (CMC)  was measured on day 5 by a  4-h 6tCr release assay. Con 
L  Abbreviations used in this paper: C, complement; CMC, cell-mediated cytotoxicily; Con A, concanavalin 
A; CTL, cytotoxic lymphocyte; FCS,  fetal  calf serum;  LNC, lymph node cell;  LPS, lipopolysaccharide 
with Fscherichia coli 0127: BS; MIIC, major histocompatibility complex: MLC, mixed lymphocyte culture; 
NMS, normal  mouse serum;  PFC, plaque-forming cell,  PItA-M, phytohemagglutinin  M;  SRBC, sheep 
erythrocytes;  Ts, T-suppressive  activity. 100 
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Fac.  1.  Qa-1  phenotypes of cells involved in the proliferative response of B6-Tla  ° spleen  cells to 
the mitogens Con A, PHA-M, and LPS. Mean data  :t: SD for four tests. Controls not shown:  B6 
spleen cells (Qa-1-) preselected  with a-Qa-1 responded similarly to B6 spleen cells preselected  with 
NMS +  C; 136 spleen cells preselected  with a-Thy-l.2 +  C gave results similar to those shown for 
a-Thy-l.2 +  C in this figure. 
A  (Difco Laboratories) stimulated BALB/c (H-2  a) spleen cells (72 h  with 4 #g/ml Con A at a 
concentration of 4  ×  106 cells/ml or P815 mastocytoma cells (H-2  a)  labeled with SZCr served 
as target  cells. Lympholysis was measured  in triplicate samples  at  target  to effector ratios of 
100:1-12.5:1.  Percent CMC was determined by the formula: 
mean cpm experimental -  mean cpm spontaneous  release 
x  100. 
mean cpm maximum release -  mean cpm spontaneous release 
Spontaneous release was determined by incubating target cells in medium alone; maximum 
release was determined by detergent lysis (5% Triton, New England Nuclear, Boston, Mass.) of 
target cells. 
Distribution  ofQa-I + Cells within the Lyt Sets.  Whether or not each Lyt set contained Qa-1 + 
cells  was  determined  by  the  following  procedure:  Lyt  and  Qa-1  antisera  were  used  in 
combination  with each other  (e.g., a-Qa-1  +  a-Lyt-l.2 or a-Qa-1  +  a-Lyt-2.2 or a-Lyt-l.2 
+  a-Lyt-2.2) in two-stage cytotoxic tests, a-Qa- 1 was used at a  final dilution of 1:50, a-Lyt-l.2 
at  1:40, and a-Lyt-2.2 at  1:10. The Ly antisera were prepared as described previously (3, 4). To 
increase the proportion  of Ly positive cells, lymph node cells were treated  with a-Ig antisera 
(provided by Dr. U. Hammerling, Sloan-Kettering Institute)  and complement as described (2) 
resulting in  70-80% Thy-1 ÷ cells. Cytotoxic indices in Table V  are calculated as a  percent of 
Thy-1 + cells. 
Results 
Qa-I  Phenotypes  of Cells Involved in Proliferative  Responses to Mitogens In  Vitro.  For this 
purpose  the proliferative responses of B6-Tla a  spleen cells preselected with a-Qa-1 
plus C  (the Qa-1- population) were compared with the responses of equal numbers of 
unselected B6-Tla ~ spleen cells (NMS  +  C). Fig.  1 shows that the Qa-1- population 
has a distinctive profile of responses to the three mitogens Con A, PHA-M, and LPS, 
implying  that  a-Qa-1  defines  a  population  of cells  not  identified  by  any  other 
antigenic system. Evidently Qa-1 ÷ cells are not essential for response to LPS (unaf- 
fected by a-Qa- 1 preselection) but are mainly responsible for the response to PHA-M 
(virtually abolished  by a-Qa-I  preselection),  either by proliferating themselves or 
possibly by inducing proliferation of Qa-1- cells.  Preselection with a-Qa-1  reduced 
the Con A response by 40%. This is in keeping with the broader reactivity of Con A 
as compared with PHA-M and suggests that the Con A responsive population includes 
both Qa-1 + and Qa-1- members. An indication that the Qa-I ÷ cells which contribute 966 
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lfic;.  2.  Uptake of [:~llJthymidine in MLC by equal numbers of B6-Tla" spleen cells preselected by 
cytolysis with a-Qa-1 (C]), ot-Thy-I ((3), or NMS (O), and stimulated with irradiated AKR cells 
(panel A) or irradiated with BALB/c cells (panel B). This figure shows one of six experiments, with 
either B6-T/a" or A/J responder cells (both Qa-1+), which gave similar results. (Controls for Qa-l 
specificity: in every test, control Qa-l- B6 or A-Tla  b responder cells pretreated with ot-Qa-I +  C 
gave values indistinguishable from B6-7"la" or A responder cells pretreated with NMS +  C.) 
tO  the  Con  A  response  do so  directly  by  proliferating  comes  from other  tests  with 
lymph node cells (LNC). Before stimulation, roughly 30% of B6- Tla" LNC are Qa- 1  +; 
after activation by Con A, roughly 50% of the blast cells are Qa-1 + (and 80% Thy-1+). 
Qa-I Phenotypes of Cells Involved in Reaction  to MHC-Incompatible Cells 
PROLIFERATION (MLC).  Removal of Thy-1 + cells markedly affected the tempo of 
the MLC response to irradiated  MHC-incompatible stimulator cells, and their  [aH]- 
thymidine  incorporation was substantially  reduced at  the time when control  (NMS 
+  C)  responder  cells  showed  maximal  incorporation  (48-72  h  after  initiation  of 
culture).  This  suggested  that  elimination  of a  proportion  of T  cells  could  best  be 
assessed in MLC assay by a  delay in the tempo of the response. Fig. 2 shows that the 
tempo and  degree of MLC  activation  in cultures  lacking Qa-1 + cells were virtually 
identical  to those of cultures of control unselected  responder cells  (NMS  +  C). The 
experiment  shown  in  Fig.  2  is one of six  such  experiments  performed,  all  of which 
gave  essentially  similar  results.  Evidently  Qa-1 +  cells  need  not  be  present  for  the 
proliferative MLC response to MHC-incompatible cells. In fact in one test elimination 
of Qa-1 ÷ cells enhanced incorporation during the 3rd day of stimulation. 
Although Qa-1 + cells are not necessary for proliferation,  measured  by MLC, they 
may nonetheless proliferate. We tested this by counting Qa-1 ÷ cells present after MLC 
with  unselected  spleen  cells.  (The stimulating  cells were Qa-1- and  therefore  could 
not contribute to the count ofQa-1 + cells.) After 72 h in culture, MLC-stimulated cell 
populations contained 41% Qa-1 + cells and 51% Thy-1 + cells, as compared with 20% 
Oa-1 + cells  and  30%  Thy-1 +  cells  in  the  unstimulated  (control)  populations.  Thus 
during MLC either Qa-1 + cells normally proliferate or the phenotype of some Qa-1- 
cells is converted to Qa-1 +. 
CMC.  The following experiments were designed to indicate the Qa-1 phenotypes 
of cells responsible  for the generation and effector function of cytotoxic lymphocytes 
(CTL).  Representative  data are shown in Table I: elimination  of Thy-1 + cells before 
MLC abolished cytotoxic activity of the stimulated  population  in subsequent  CMC 
assays, but elimination of Qa-1 + cells before MLC did not, indicating that Qa-1 + cells 
are not required  for the generation of CTL. Elimination  of Thy-1 + cells after MLC, 
immediately  before  CMC  assay,  greatly  reduced  lytic  activity.  CTL  generated  in 
MLC seem relatively resistant to ot-Thy-1  +  C, and complete elimination ofcytolytic 
function  was  not  achieved  in  all  experiments  despite  two  cycles  of exposure  to or- STANTON  ET  AL. 
TABLE  I 
Qa-1 Phenotypes of B6-Tla a Cells Involved in the Generation and Effector Function of Cytotoxic 
Lymphocytes against MHC-lncompatible  ( BALB/c)  Target Cells 
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Treatment of re-  Treatment of re- 
Source of responder  sponder ceils before  sponder ceils after 
cells  MLR*  MLR* 
Cytolytic activity961ysis % 
lysis (E:T~ ~  12.5:1) 
Exp. l  Exp. 2  Exp. 3 
Spleen 
Lymph nodes 
NMS +  C  --  59  24  20 
a-Qa-I +  C  --  56  21  27 
a-Thy-I +  C  --  <5  <5  <5 
--  NMS  +  C  71  76  55 
--  a-Qa-i +  C  74  51  58 
--  a-Thy-1  +  C  40  24  4 
% lysis  (E:T~ --  10:1) 
Exp. 1 
NMS +  C  --  19 
a-Qa- I +  C  --  46 
--  NMS  +  C  24 
--  a-Qa-I +  C  29 
Exp. 2  Exp. 3 
10  28 
25  67 
* After antiserum  +  C treatment, the numbers  of remaining  viable cells were 
lymphocyte reaction. 
Effector-cell:target cell (ratio). 
equalized. MLR, mixed 
Thy-1  +  C. Elimination ofQa-1 + cells (two cycles of exposure to a-Qa-1  +  C), after 
MLC,  did  not  reduce  CMC  activity,  indicating  that  CTL,  in  this  experimental 
system,  are  Qa-l-.  In  fact,  these  data  indicate  that  Qa-I +  LNC  may  exert  an 
inhibitory effect upon the generation of CTL. 
Thus  major histocompatibility complex  (MHC)-alloreactive Lyt-23 prekiller and 
killer effector cells are apparently Qa-1-. No conclusions, however, should be drawn 
concerning the Qa-1 phenotype of Lyt-1 + TH cells that amplify the response of Lyt-23 
allogeneic prekiller cells because help and  suppression are probably generated  con- 
comitantly  (12),  and  thus  a  reduction  in  helper  activity  could  be  balanced  by 
reduction of suppression. 
Qa-I Phenotypes  of Cells Involved in the Production  of Antibody to SRBC 
INFLUENCE  OF  Qa-t +  CELLS  ON  PRIMARY  AND  SECONDARY  RESPONSES  TO  SRBC  IN 
VITRO.  Table II shows that the primary a-SRBC PFC response of the Qa- 1- spleen 
population (selected with a-Qa-1  +  C), on day 5 of cuhure, was more than six times 
that  of equal  numbers  of the unselected population  (NMS  +  C).  The  response of 
Qa-1-  spleen  cells from  SRBC-primed  mice,  on  day  4  of culture,  was  more  than 
double  that  of the  unselected  population.  These  increments  in  PFC  values for the 
Qa-1-  population  were  sufficiently  high  to  suggest  that  they  might  be  due  to 
elimination of suppression by the missing Qa-1 ÷ cells. This proposal was tested in the 
experiments reported below. 
CONTRIBUTION  OF  Qa-1 +  CELLS TO  T-SUPPRESSIVE  ACTIVITY (TABLE IU).  (a)  SRBC- 
induced suppressor activity: B6-Tla a spleen cells were cultured with SRBC for 3 days 
to  generate  a-SRBC  suppression  and  were  then  added  in  graded  numbers,  with 968  Qa-1 + LYMPHOCYTES 
TABLE  II 
Participation  of Qa-1 + Cells in Primary and Secondary a-SRBC PFC Responses 
in  Vitro 
Antibody response 
to SRBC in vitro 
Primary* 
Secondary:~ 
B6- TIa  a spleen cells 
selected with: 
PFC response 
(% of standard) 
Day 4  Day 5 
NMS +  C (standard)  (100)  (100) 
et-Thy- 1 +  C  5  4 
a-Qa- 1 +  C  235  640 
f  NMS  +  C  (standard)  (100)  (100) 
a-Thy-1  +  C  8  ND 
a-Qa-I  +  C  225  ND 
* Mean  data  for  fi.ur  experiments;  the  range of values  for controls  (NMS  + 
standard)  was  1,200-4,100 direct PFC per culture. 
:~ Mean  data  for  three experiments;  the range of values  for controls  (NMS  + 
standard)  was  1,800-4,400 indirect PFC per culture. 
TABLE  III 
Contribution of Qa-1 + Cells to SRBC-Indueed Suppression* 
C~ 
C: 
Treatment of  Treatment of  Cells added to fresh spleen cell cultures 
spleen cells before  spleen cells after 3 
stimulation by  days stimulation by  2 ×  10  ~  5 ×  104  5 ×  103 
SRBC in vitro  SRBC in vitro  % reduction in PFC:]: (day 4) 
None  NMS +  C  81  ±  4  52  ±  5  <10 
None  a-Qa-I  +  C  57  ±  6  <10  <10 
a-Qa-I  +  C  NMS +  C  26 ±  5  <10  <10 
None  a-Thy-1  +  C  <10  <10  ND 
* Mean data for four experiments in which the control values for 107 normal spleen 
cells plus SRBC (standard)  without  addition of educated cells averaged 8,410  + 
3,650. 
:~ 100 -  mean PFC count per culture/mean PFC count per control culture. 
SRBC,  to  cultures  of  107  unprimed  B6  spleen  cells.  As  indicated  in  Table  III, 
elimination of Qa-1 ÷ cells before induction of anti-SRBC  suppressor  activity resulted 
in  a  substantial  (> 10-fold)  reduction  in  the ability of the  residual  Qa-1-  population 
to  generate  a-SRBC  suppression.  Elimination  of Qa-1 ÷  cells  after  induction  of a- 
SRBC  suppressor  activity  also  resulted  in  considerable  (~10-fold)  reduction  of T- 
suppressive  activity. The Qa-1  specificity of elimination  in  this study  was confirmed 
in  control  experiments  in  which  suppression  was  not  abrogated  in  parallel  tests  in 
which  B6  (Qa-1-)  spleen  cells were  subjected  to  the  same  selection  procedure  with 
a-Qa- 1  +C. 
(b)  Con A-induced suppressive activity: under certain conditions,  inclusion of Con 
A  in  SRBC-stimulated  spleen  cell  cultures  results  in  a  substantially  reduced  PFC 
response,  and  this  is  due  to  suppressive  effects  of  Thy-1 ÷  cells  (6,  8,  12).  Such 
suppression  was  virtually  eliminated  if Qa-I +  cells  were  removed  from  spleen  cells 
before  culture  (Table  IV;  A).  To  determine  whether  Qa-1 +  cells  were  essential  for 
both  generation  of  T-suppressive  (Ts)  activity  as  well  as  for  suppressor-effector 
activity, T  cells (nylon wool purified)  were selected with a-Qa-1  +  C  either before or STANTON ET AL. 
TABLE IV 
Con A m Relation to Qa-1  + Cells and Suppression 
(A)  Suppression of the  primary  in vitro SRBC PFC  response by Con A: 
contribution of Qa- 1  ÷ cells* 
% reduction 
T-Cell population  Exp. 1  Exp. 2 
Unselected  98  96 
Qa-1-  39  0 
(B) Contribution of Qa-1  + cells to generation of'Is after Con A stimulation:l: 
Treatment of cells  Treatment of cells  Cells added to fresh SRBC- 
before in vitro  after in vitro  stimulated spleen cells 
stimulation by  stimulation by  2 ×  105  5 ×  104 
Con A  Con A 
% reductions§ 
None  NMS +  C  68-1" 10  40 +  17 
a-Qa-1 +  C  NMS +  C  45 +  6  21  ±  4 
None  a-Qa-1 +  C  61  +  ll  34 +  7 
None  ot-Thy-  1 +  C  0  0 
* Cells of the indicated T-cell population +  5 ×  10  s B cells (selected with 0t- 
Thy-l.2 +  C ×  2) were incubated with 5 p,g/ml Con A +  3 ×  10  s SRBC, 
and assayed for PFC on day 5. 
Graded numbers of the indicated T-cell population +  10  r unprimed spleen 
cells +  3 ×  106 SRBC were cultured for 4 days. 
§ 100 -  mean PFC count per culture/mean PFC count per control culture. 
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after stimulation by Con A  and were then added  in graded  numbers to  107 spleen 
cells. Table IV (B)  shows that although Qa-1 ÷ cells contribute to the initiation of Ts 
activity by Con A  (line 1 compared to  line 2), Ts activity, once generated, was no 
longer susceptible to elimination by a-Qa-1  +  C  (line 1 compared to line 3). These 
data, taken together, indicate that Qa-1 ÷ cells are required for generation of antigen- 
induced and, to a lesser extent, for optimal Con A-induced Ts activity: once generated, 
Con  A-induced suppressive  activity  does  not  require  the  continuous presence  of 
Qa-1 ÷ cells while SRBC-induced suppressive activity does. 
Representation  of Qa-I Phenotypes  Within  Various T-Cell Sets (Tab&  V).  Approximately 
70% of Thy-1  ÷ cells are Qa-1 ÷. Since this Thy-l+.:Qa-I  + set is larger than any of the 
Lyt sets estimated for B6 spleen and lymph node cells (33% Lyt-l; 5-10% Lyt-23; 50% 
Lyt-123;  expressed  as  proportions  of  the  Thy-1  ÷  population  [9]),  Qa-1  must  be 
expressed on more than one Lyt-defined T  cell set. To determine which sets contain 
Q a-1 + cells, we enumerated B6-Tla a peripheral LNC by cytotoxicity assays with a- 
Qa-1, a-Lyt-l.2, and a-Lyt-2.2 sera either alone or in combination. 
The combined antiserum method indicates a small proportion of Lyt-:Qa-1  + cells, 
because more cells were lysed by the a-Lyt plus a-Qa-1  combinations than by any 
ct-Lyt  serum  alone.  It  is  acknowledged  that  lysis with  two  antisera  may  be  more 
efficient  than  lysis  with  either  antiserum alone,  and  that  this  would  stimulate a 
proportion of cells expressing only one of the two antigens. But this is unlikely to be 
the main explanation of the apparent Lyt-:Qa-1  + cell set, because a small proportion 
of Thy-1-:Qa-1  ÷ cells is detectable in normal (2) and in LPS-stimulated populations. 
That issue aside, the data shown in Table V  are our estimations of the phenotypes 970  Qa-1 +  LYMPHOCYTES 
TAaLE  V 
Representation of Qa-I + Phenotypes among Lyt Cell Sets 
Designation  Thy-I ÷ cells treated with  Lysis (cytotoxicity index)* 
A  ot-Qa- 1 +  C  78 
B  a-Lyt-1  +  C  .90 
C  ot-Qa-1  +  ot-Lyt-I  +  C  100 
D  a-Lyt-2  +  C  69 
E  a-Lyt-2  +  a-Qa-I  +  C  89 
F  ot-Lyt-I  +  a-Lyt-2  +  C  98 
l~yt Sets trnplied by these  data 
G  a-Lyt-I  ffi  29  (F-D) 
tl  l,yt-23  ffi 8  (F-B) 
I  Lyt-123  ---  61  (B-G or D-H) 
Observat ion 
Cells bearing Qa-I  =  78% (A) 
Qa-I  is  expressed  on  more  T-cells  than  belong  to  any 
single Lyt set 
Cells bearing both Qa-I  and Lyt-I  =  68% (A  +  B -  C) 
Qa-~,  is expressed  on  more  Lyt-1 +  cells  than  belong  to 
either the Qa-i  or the Lyt-123 sets 
Cells bearing both Qa-I and Lyt-2  =  58% (A  +  D  -  E) 
Qa-I  is expressed on 84% of Lyt-2 + cells 
Q a-l  Distribution  within  the Lyt sets implied by these data: 
Inference 
Qa- 1 is expressed on more than one Lyt set 
Q a- 1 is expressed on some members of both 
Lyt-I  and Lyt-123 sets 
At least 82% of Lyt- 123 cells are Qa- 1  + 
* All cytotoxic indices and thus all other percentages are expressed as percent of Thy-1 + cells. 
and proportions of cell sets identified by the Thy-1, Lyt, and Qa-1  systems. Accord- 
ingly we believe  the Lyt-123  cell  set  to be approximately  80% Qa-1 +,  and that the 
Lyt-1 set comprises Qa-1 ÷ and Qa-1- subsets in about equal proportions. The precise 
proportion of Qa-1 + cells within the Lyt-23 could not be reliably evaluated because 
of the relatively small proportion of the Lyt-23 set in the T  cell population. 
Discussion 
The genetic disparity involved in the immunization  (B6  X  A-Tla b)  anti-A (Tla"), 
which defines the Qa-1  system, concerns a region of chromosome  17 reaching from a 
crossover point between H-2D and Tla and extending to a presently unmarked point 
beyond  Tla.  It  is already  clear  that  genes  in  this  region  define  several  cell  surface 
components,  including the TL  antigens  of thymocytes,  histocompatibility  antigens 
responsible  for  skin  graft  incompatibility,  and  the  group  of serologically  defined 
antigens collectively termed  Qa.  Qa itself has already been shown to encompass  at 
least three systems, Qa-1, Qa-2, and Qa-3 (10, 11), by serological analysis of Flaherty's 
B6.K1  and  B6.K2  strains  derived  from  different  recombinants  between  H-2D  and 
Tla. Qa-2 and Qa-3 do not enter the picture as far as the present study is concerned 
because B6 and A  (the allele donor of the recombinant congenic B6-Tla a strain) have 
so-far indistinguishable Qa-2 and Qa-3 types. 
It is impossible at the moment to say how many cell surface components Qa-1 may 
comprise, nor whether each belongs to a different program that subclassifies  the Lyt 
and perhaps other lymphocyte sets.  Although the immunization  of (B6  ×  A-Tla o) 
mice  is  performed  with  the  TL +  leukemia  ASLI,  it  does  not  follow  that  ASL1 STANTON ET AL.  971 
expresses all Qa-1 antigens that may be represented in the antiserum, because splenic 
ASL1 cell suspensions include a variety of normal A strain cells.  Although analysis is 
as yet far from complete, the Qa-1 system is already of considerable value because it 
distinguishes a population of iymphocytes that is not defined by any other antigenic 
system, according to three criteria:  (a) representation of Qa-1 cells among T  cell sets 
defined  by  Lyt phenotypes,  (b)  the  profile of responses  to  mitogens  exhibited  by 
lymphocyte  populations  depleted  of Qa-I +  cells,  and  (c)  the  profile  of immune 
responses of lymphocyte populations depleted of Qa-I ÷ cells. 
Mitogens, as polyclonal activators of lymphocytes, have been a valuable aid in the 
study of lymphocyte function and the dissection of lymphocyte sets.  In this respect it 
is  noteworthy that  Qa-I + cells, which  compose part  of the  Lyt-1  and  Lyt-123 sets 
(their  representation  in  the  Lyt-23  set  is  unknown),  are  essential  for  significant 
responses to PHA and are required for optimal responses to Con A. By the criterion 
of SRBC PFC production by spleen cells, Con A induces both helper and suppressor 
functions (6, 12) and has been shown to stimulate all three Lyt T  cell sets (6); whereas 
PHA  appears  to  induce  mainly suppression  but  not  help,  and  other studies  have 
indicated  that  optimal  response to PHA,  unlike Con A,  may require Lyt-123 cells 
(13). It may be that Con A can induce Lyt-123+:Qa-1 + cells to become Lyt-23+:Qa-I - 
suppressor  cells;  in  the  absence  of Lyt-123  cells  Con  A  can  activate  populations 
enriched  for  Lyt-23  cells  to  express  suppressive  activity.  Thus  Con  A-activated 
suppression of the a-SRBC PFC response was reduced by elimination of Qa-1 + cells 
during the generative phase, at a time when amplifiers or precursors (or both) would 
most likely be needed. This was particularly evident when Con A-induced inhibition 
depended upon rapid generation of suppressor cells during a  5 day in vitro primary 
response  (Table  IV,  A).  Once  generated,  Con  A-induced  suppressor  cells  were 
insensitive  to  elimination  of Qa-I +  cells.  By  contrast  Qa-I +  cells  were  evidently 
required for both generation and effector function of SRBC-induced suppression of 
the  a-SRBC  response.  This  may  imply  that  SRBC-specific  Qa-1 ÷  cells  generate 
additional suppression during restimulation by SRBC in the assay cultures. 
In  any  event,  the  participation  of Qa-I +  ceils  in  the  regulation  of the  SRBC 
antibody response is a remarkable feature of the Qa- 1 system and is primarily reflected 
in the generation of a T-cell suppressor (Ts) population (14-16). This is the evident 
reason why elimination of Qa-1 + cells so greatly augments the primary response to 
SRBC in vitro. Recent experiments have shown that cells of Lyt- 123:Qa- 1  ÷ phenotype 
can be induced by antigen-stimulated Lyt-1 :Q  a-1 ÷ cells to develop substantial  feed- 
back suppressive activity (15,  16). We no not know (a)  whether Lyt-123:Qa-1 + cells 
are accessories needed to assist in optimal generation of suppressor-effectors, or give 
rise  directly  to  suppressor-effectors after  induction  by  Lyt-l:Qa-1  +  ceils;  nor  (b) 
whether Lyt-I  inducer cells and  resting  Lyt-123 cells express identical Qa-1 region 
gene products. 
The prominence of Qa-1  ceils in suppression of the SRBC  antibody response in 
PFC assays contrasts with the minimal influence of Q a-1 + cells in MLC assays, and 
in both the generation and effector function of cytotoxic lymphocytes active in CIMCI 
assays.  Evidently alloreactive prekiller and  killer cells are  Lyt-23+:Qa-1 -.  Whether 
the same applies  to the generation  and  effector function of cytotoxic lymphocytes 
generated against  virally or chemically modified cells remains to be seen;  this is of 
special interest because in this case Lyt-123 precursors are necessary for generation of 
optimal numbers of Lyt-23 cytotoxic effector cells (17). 972  Qa-I +  LYMPHOCYTES 
Summary 
The antiserum (B6 X  A-Tla  b) anti-A (Tla  a) defines several TL antigens expressed 
exclusively on  thymocytes.  When  reacted  with  peripheral  lymphocytes, the  same 
antiserum defines another antigenic system, provisionally termed Qa- 1. The genotypic 
disparity distinguishing the recipients and donors in this immunization comprises a 
section of chromosome 17 extending from a crossover point between H-2D and Tla to 
a presently unmarked point beyond Tla. Therefore although Qa-1  may constitute a 
single cell surface component, it is equally probable that the Qa-1 system defines two 
or more cell surface components determined by genes in  this region, each of which 
may be expressed on a different cell set. 
Cytotoxicity assays  indicate  that  Qa-1  antigen  is  expressed  on  Lyt-I  cells  and 
Lyt-123 cells, and may serve to subclassify these two cell sets; it is not known whether 
Qa-1 + cells may occur within the small Lyt-23 set. There may also be a cell set with 
the phenotype Thy- l-:Qa- 1  +. 
Another  distinctive  feature  of the  Qa-1  system  is  the  characteristic  profile  of 
responses to mitogens exhibited by spleen cell populations from which Qa-1 + cells 
have  been  eliminated;  in  conventional  assay  of [3H]thymidine  incorporation  the 
response to lipopolysaccharide was essentially unchanged, the response to phytohe- 
magglutinin M  (PHA-M) was virtually abolished, and the response to concanavalin 
A  (Con A) was reduced by 40%. 
The  third  distinctive  feature of the  Qa-1  system  is  the  characteristic  profile of 
changes which elimination  of Qa-1 ÷ cells produces in  tests of immune  function in 
vitro: (a) proliferation, measured by [3H]thymidine incorporation, in mixed lympho- 
cyte culture  (MLC)  with  major  histocompatibility complex  (MHC)-incompatible 
stimulator cells, was not affected. (b) in tests of cell-mediated cytotoxicity (CMC) of 
MHC-incompatible target cells,  neither the generation nor the effector functions of 
cytotoxic lymphocytes was affected, implying that Lyt-23 prekiller and killer cells are 
Qa-1-. (c) primary and secondary responses to SRBC were considerably augmented, 
suggesting that Qa-1 + cells may be responsible for suppression in this test system. (d) 
accordingly the suppression of the anti-sheep erythrocyte (SRBC) response normally 
engendered in spleen cells by culture with SRBC was profoundly reduced by elimi- 
nation of Qa-1 + cells, either before or after culture.  (e)  the suppression of the anti- 
SRBC response normally engendered in spleen cells cultured with Con A was reduced 
by removal of Qa-1 + cells before but not after culture with Con A. 
Although analysis is as yet far from complete, the Qa-1  system should already be 
of considerable value because it distinguishes a population of lymphocytes that is not 
defined by any other antigenic system, according to three criteria: (a) representation 
of Qa-1 cells among T-cell sets defined by Lyt phenotypes, (b) the profile of responses 
to mitogens exhibited by lymphocyte populations depleted of Qa-1 + cells, and (c) the 
profile of immune responses of lymphocyte populations depleted of Qa-1 + cells. 
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